Breakthrough in Reversible Male Contraception (news.cornell.edu)

• Non-hormonal mechanism targeting sperm motility.
• Full reversal of effects confirmed in preclinical testing.
• Significant advancement in reproductive biotechnology.

"Researchers have achieved a significant milestone in developing a non-hormonal, reversible male contraceptive. The method targets specific protein interactions required for sperm motility without disrupting natural hormone regulation. Preclinical trials demonstrate high efficacy and rapid return to fertility post-treatment. This development offers a paradigm shift in reproductive healthcare, potentially expanding family planning options and reducing the burden of contraception traditionally carried by women, while aligning with future pharmaceutical research priorities for European health sovereignty."